User profiles for Jeremy K. Nicholson
Jeremy K NicholsonAustralian National Phenome Center, Murdoch University + Imperial College London Verified email at murdoch.edu.au Cited by 122111 |
'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR …
The rapid evolution of drug discovery science, fuelled by combinatorial librarybased synthesis
programmes, has led to increased pressure on the drug safety evaluation process. Once …
programmes, has led to increased pressure on the drug safety evaluation process. Once …
Host-gut microbiota metabolic interactions
The composition and activity of the gut microbiota codevelop with the host from birth and is
subject to a complex interplay that depends on the host genome, nutrition, and life-style. The …
subject to a complex interplay that depends on the host genome, nutrition, and life-style. The …
Metabonomics: a platform for studying drug toxicity and gene function
JK Nicholson, J Connelly, JC Lindon… - Nature reviews Drug …, 2002 - nature.com
The later that a molecule or molecular class is lost from the drug development pipeline, the
higher the financial cost. Minimizing attrition is therefore one of the most important aims of a …
higher the financial cost. Minimizing attrition is therefore one of the most important aims of a …
Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts
Metabolic profiling, metabolomic and metabonomic studies mainly involve the multicomponent
analysis of biological fluids, tissue and cell extracts using NMR spectroscopy and/or mass …
analysis of biological fluids, tissue and cell extracts using NMR spectroscopy and/or mass …
Metabonomics
JK Nicholson, JC Lindon - Nature, 2008 - nature.com
Organisms often respond in complex and unpredictable ways to stimuli that cause disease
or injury. By measuring and mathematically modelling changes in the levels of products of …
or injury. By measuring and mathematically modelling changes in the levels of products of …
OPLS discriminant analysis: combining the strengths of PLS‐DA and SIMCA classification
…, O Cloarec, JK Nicholson… - … of Chemometrics: A …, 2006 - Wiley Online Library
The characteristics of the OPLS method have been investigated for the purpose of discriminant
analysis (OPLS‐DA). We demonstrate how class‐orthogonal variation can be exploited …
analysis (OPLS‐DA). We demonstrate how class‐orthogonal variation can be exploited …
Understanding'global'systems biology: metabonomics and the continuum of metabolism
JK Nicholson, ID Wilson - Nature Reviews Drug Discovery, 2003 - nature.com
… (Princeton University), Professor Jeremy Everett (Pfizer Global Research, UK) and Dr
Felicity Nicholson for their helpful comments and discussion on this work and related subjects. …
Felicity Nicholson for their helpful comments and discussion on this work and related subjects. …
Human metabolic phenotype diversity and its association with diet and blood pressure
…, H Kesteloot, H Ueshima, L Zhao, JK Nicholson… - Nature, 2008 - nature.com
Metabolic phenotypes are the products of interactions among a variety of factors—dietary,
other lifestyle/environmental, gut microbial and genetic 1 , 2 , 3 . We use a large-scale …
other lifestyle/environmental, gut microbial and genetic 1 , 2 , 3 . We use a large-scale …
Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics
Although a wide range of risk factors for coronary heart disease have been identified from
population studies, these measures, singly or in combination, are insufficiently powerful to …
population studies, these measures, singly or in combination, are insufficiently powerful to …
Pharmaco-metabonomic phenotyping and personalized drug treatment
There is a clear case for drug treatments to be selected according to the characteristics of
an individual patient, in order to improve efficacy and reduce the number and severity of …
an individual patient, in order to improve efficacy and reduce the number and severity of …